Incannex Healthcare (IXHL) Revenue (2024)
Incannex Healthcare's (IXHL) quarterly Revenue came in at $12000.0 in Q4 2024, down 83.78% quarter-over-quarter from $74000.0 in Q3 2024.
Incannex Healthcare (IXHL) Revenue (2024) Analysis & Trends
Incannex Healthcare has disclosed Revenue across 1 years of filings, most recently posting $12000.0 for Q4 2024.
- Revenue for Q4 2024 came in at $12000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $86000.0 (changed N/A YoY), and the FY2025 annual result was $86000.0, up 616.67% from the prior year.
- Revenue came in at $12000.0 for Q4 2024 at Incannex Healthcare, down from $74000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $74000.0 in Q3 2024 to a low of $12000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 608.10 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 377.33 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 74,000.00 |